<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Garg V</submitter><funding>NHLBI NIH HHS</funding><pagination>307-24</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3434097</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>140(3)</volume><pubmed_abstract>Ether-à-go-go (EAG) and EAG-related gene (ERG) K(+) channels are close homologues but differ markedly in their gating properties. ERG1 channels are characterized by rapid and extensive C-type inactivation, whereas mammalian EAG1 channels were previously considered noninactivating. Here, we show that human EAG1 channels exhibit an intrinsic voltage-dependent slow inactivation that is markedly enhanced in rate and extent by 1-10 µM 3-nitro-N-(4-phenoxyphenyl) benzamide, or ICA105574 (ICA). This compound was previously reported to have the opposite effect on ERG1 channels, causing an increase in current magnitude by inhibition of C-type inactivation. The voltage dependence of 2 µM ICA-induced inhibition of EAG1 current was half-maximal at -73 mV, 62 mV negative to the half-point for channel a</pubmed_abstract><journal>The Journal of general physiology</journal><pubmed_title>Tuning of EAG K(+) channel inactivation: molecular determinants of amplification by mutations and a small molecule.</pubmed_title><pmcid>PMC3434097</pmcid><funding_grant_id>HL55236</funding_grant_id><funding_grant_id>R01 HL055236</funding_grant_id><pubmed_authors>Garg V</pubmed_authors><pubmed_authors>Sachse FB</pubmed_authors><pubmed_authors>Sanguinetti MC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tuning of EAG K(+) channel inactivation: molecular determinants of amplification by mutations and a small molecule.</name><description>Ether-à-go-go (EAG) and EAG-related gene (ERG) K(+) channels are close homologues but differ markedly in their gating properties. ERG1 channels are characterized by rapid and extensive C-type inactivation, whereas mammalian EAG1 channels were previously considered noninactivating. Here, we show that human EAG1 channels exhibit an intrinsic voltage-dependent slow inactivation that is markedly enhanced in rate and extent by 1-10 µM 3-nitro-N-(4-phenoxyphenyl) benzamide, or ICA105574 (ICA). This compound was previously reported to have the opposite effect on ERG1 channels, causing an increase in current magnitude by inhibition of C-type inactivation. The voltage dependence of 2 µM ICA-induced inhibition of EAG1 current was half-maximal at -73 mV, 62 mV negative to the half-point for channel a</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Sep</publication><modification>2026-05-03T05:19:24.245Z</modification><creation>2019-03-27T00:57:29Z</creation></dates><accession>S-EPMC3434097</accession><cross_references><pubmed>22930803</pubmed><doi>10.1085/jgp.201210826</doi></cross_references></HashMap>